• Common diabetes drug linked to low risk of major heart issues
    Toronto, September 24 (IANS): Drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with a lower risk of major heart problems in patients with type 2 diabetes than dipeptidyl peptidase-4 (DPP-4) inhibitors, say, researchers. According to the study, published in the journal The BMJ, previous trials have shown that SGLT2 inhibitors can reduce the risk of heart conditions such as heart attack, stroke, and heart failure compared with placebo. But some of the
  • Men at 62% increased risk of Covid associated deaths: Study
    London, September 24 (IANS): New research has added to the growing body of evidence that men have a 62 per cent greater risk of Covid-19 associated death compared to women, possibly due to higher levels of inflammation. Increasing evidence suggests a gender difference in SARS-CoV-2 infections. In most cohorts, men are overrepresented and previously published data show a higher incidence of severe courses of Covid-19 in men. According to the study presented on at ESCMID Conference
  • Breathing problems key reason for not wearing masks: Study
    New Delhi, September 24 (IANSlife): When it came to non-compliance towards covering face, breathing problems have emerged as a key reason, with 50 percent listing it in a nationwide survey, followed by discomfort and inconvenience at 44 per cent. Around 45 percent also assume that as long as social distancing was maintained, a mask was not required. The survey, spread over 18 cities, was initiated by ApnaMask, an initiative by EkDesh, to understand overall compliance around wearing
  • Fujifilm's Avigan shown to be effective in Japanese Phase-3 trial for COVID-19
    TOKYO, September 23 (Reuters) : Fujifilm Holdings Corp said on Wednesday a late-stage study of its antiviral drug Avigan showed it reduced recovery times for COVID-19 patients with non-severe symptoms, boosting expectations for regulatory approval in Japan. The Phase 3 clinical study of 156 patients in Japan showed that those treated with Avigan improved after 11.9 days, versus 14.7 days for a placebo group. Results of the study, conducted by subsidiary Fujifilm Toyama Chemical, wer
  • Punjab to start Covaxin's Phase-3 trials
    Chandigarh, September 22 (IANS): Punjab's three Government Medical Colleges will participate in the Phase-3 trials of Bharat Biotech Ltd's Covaxin, the first indigenously-developed vaccine candidate against coronavirus, in collaboration with the Indian Council of Medical Research (ICMR), an official said on Tuesday. The trials are scheduled to commence from October 15. This was disclosed by a government spokesperson fter a virtual Covid review meeting chaired by Chief Min
  • Study suggests dengue may provide some immunity against COVID-19
    RIO DE JANEIRO, September 22 (Reuters) - A new study that analyzed the coronavirus outbreak in Brazil has found a link between the spread of the virus and past outbreaks of dengue fever that suggests exposure to the mosquito-transmitted illness may provide some level of immunity against COVID-19. The not yet published study led by Miguel Nicolelis, a professor at Duke University, and shared exclusively with Reuters, compared the geographic distribution of coronavirus cases with the
  • Breast cancer drug shows promise to change prostate cancer treatment
    London, September 21 (IANS): A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer, showed results of a major trial which could change clinical practice. Final results from the trial showed that olaparib -- a pioneering type of drug called a PARP inhibitor, a cancer drug to target an inherited genetic fault -- can be used successfully to treat prostate cancers with a weakness in their ability to repair damaged DNA. The drug was more
  • Over 60K sign up for Russian Covid vax, 700 injected
    Moscow, September 21 (IANS): More than 60,000 people have applied to volunteer for the coronavirus vaccine trials in Moscow and over 700 people have been injected with the coronavirus vaccine, the media reported. Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund and registered on August 11. "Over 60,000 people have signed up as volunteers,
  • Certain cancer treatments up death risk from Covid-19: Study
    New York, September 20 (IANS): A team of US researchers has found that certain treatments for cancer may increase the chance of death if they contract Covid-19. The study by the researchers at the University of Cincinnati, presented at the European Society for Medical Oncology Virtual Congress 2020, shed light on ways standard anti-cancer treatments may impact outcomes for patients with both cancer and the coronavirus. "Patients with cancer are susceptible to infection from
  • 8 risk factors that can lead to heart failure
    New Delhi, September 20 (IANSlife): Heart failure is one of the most under-diagnosed heart diseases in our country, contributing to a high number of death rates. The National Heart Failure Registry recently revealed its one-year data, which shows that close to 17 percent of patients die within 90 days of being diagnosed with heart failure. These high death rates are comparable to mortality associated with cancers of the breast and cervix. There is lot of ambiguity when it comes to u
  • Drug with potential to fight Covid-19 identified
    London, September 19 (IANS): Scientists have identified a new drug that could prevent or mitigate the consequences derived from infection by SARS-CoV-2, the virus responsible for Covid-19. Preliminary results of the study conducted on animal models showed that the drug 4-Phenylbutiric acid (4-PBA) fully curbs mortality caused by respiratory failure derived from cellular stress, showed the research published in the journal Cytokine and Growth Factors Review. The inflammatory proce
  • If you do not snooze you lose: sleep seen as essential for the brain
    WASHINGTON, September 19 (Reuters): Scientists are providing a fuller understanding of the essential role that sleep plays in brain health, identifying an abrupt transition at about 2.4 years of age when its primary purpose shifts from brain building to maintenance and repair. Researchers on Friday said they conducted a statistical analysis on data from more than 60 sleep studies. They looked at sleep time, duration of rapid eye movement (REM) sleep, brain size and body size, a
  • Phase 3 trial of Oxford vaccine to begin in Pune from next week
    New Delh, September 19 (PTI): The Phase 3 human clinical trial of the COVID-19 vaccine developed by Oxford University and being manufactured by the Serum Institute of India (SII) will begin at the Sassoon General Hospital in Pune next week. Dean of the state-run Sassoon General Hospital Dr Muralidhar Tambe told this to PTI on Saturday. "The phase-III trial of 'Covishield' vaccine will begin at Sassoon hospital from next week. It is likely to start on Monday. Some vol
  • Had a hectic week? Just 10 minutes of massage will relax you
    London, September 19 (IANS): If you have had a tiring week, just 10 minutes of simple massage at home can do wonders to rejuvenate your mind and body, suggests a new research. All you need to do is find someone to do that for you. Even ten minutes of simple rest increases relaxation, albeit to a lesser degree than massage, showed the research published in the journal Scientific Reports. This study indicates that massage is an easy-to-apply intervention that can boost the body&
  • Patients suffering from COVID-19 are facing cardiac issues
    New Delhi, September 18 (IANSlife): The original thought was that the novel coronavirus is a respiratory disease, but as the number of patients who have contracted the virus are increasing, it has become clear that COVID-19 has several other implications. The impact of COVID-19 goes beyond the respiratory system and the lungs, it has tremendous impact on the cardiovascular system of the human body as well. Reports have suggested that heart failure has been one of the main causes of
  • What you need to know about the coronavirus right now
    Reuters Here's what you need to know about the coronavirus right now: Past the 30 million mark Global coronavirus cases exceeded 30 million on Thursday, according to a Reuters tally, with the pandemic showing no signs of slowing. India was firmly in focus as the latest epicentre, although North and South America combined still accounted for almost half of the global cases. The south Asian nation, the world's second-most populous country, has been reporting more new
  • Pfizer vaccine trial bets on early win against coronavirus, documents show
    September 18 (Reuters) - Pfizer Inc is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents reviewed by Reuters that describe how the trial is being run. In recent weeks, Pfizer has said it should know by the end of October whether the vaccine, developed together with Germany's BioNTech SE, is safe and effective. If the vaccine is shown to work by then, Pfizer has sai
  • Tips for managing mental health during COVID-19
    NEW YORK, September 17 (Reuters):  Months in, the pandemic continues to take a toll on mental health. As part of our #AskReuters Twitter chat series, Reuters gathered a group of experts to share their tips on coping with isolation, caregiving and more. Below are edited highlights. How does isolation affect mental health? What are some strategies we can use to find community during a lockdown? “Before the pandemic, we were already in the middle of a mental healt
  • Wearing eyeglasses may lower the risk of Covid-19: Study
    New Delhi, September 17 (IANS): A small yet significant study from China has found that people who wear eyeglasses may be at a lower risk of contracting Covid-19 as the virus may enter the body via eyes. The study involving 276 patients hospitalised with Covid-19 in Suizhou, China, found that the proportion of daily wearers of eyeglasses was lower than that of the local population (5.8 per cent vs 31.5 per cent). "We hypothesized that eyeglasses prevent or discourage wearers
  • Smoking linked to bleeding in the brain: Study
    London, September 17 (IANS): Smoking most likely has a significant share in all cases of subarachnoid haemorrhage, the most fatal type of cerebrovascular disturbances in the brain, warn researchers. The study, published in the journal Stroke, reaffirmed a link between smoking and subarachnoid haemorrhage (SAH), a type of bleeding stroke that occurs under the membrane that covers the brain and is frequently fatal. "Our study provides evidence about the link between smoking an